Fitch Ratings, in its recently released report, said that the sales of Indian pharmaceutical companies will rise after a gradual easing of the Coronavirus pandemic-related lockdown measures that caused disruptions across most markets in the first quarter of FY21

Biocon's subsidiary Biocon Biologics India Ltd, a fully-integrated pure-play biosimilars company and Mylan announced the launch of Semglee (insulin glargine injection) in the US to expand access for diabetes patients

Anil Ambani-led Reliance Infrastructure informed the bourses on Monday that it has defaulted on the repayment of a loan. The company's stock has deteriorated almost 95 in the last couple of years. The company in its latest quarterly filing has said that it has nearly Rs 60,000 crore of receivables pending

In the recently released report, India Ratings & Research (Ind-Ra) has expressed that despite the share of agriculture in India's gross value, which is 17 per cent, the rural demand at best can extend support to consumption demand but cannot be a substitute for urban demand

Ramco Systems informed the bourses on Tuesday that it has entered into a multi-million dollar agreement with leading utilities and infrastructure group with diversified businesses in Malaysia

CRISIL expects India’s retail food inflation, which is measured through consumer price index (CPI), to cool down in the second half of the ongoing fiscal year on account of the effect of the high base of the previous year, along with a bumper Rabi harvest and a good prospect of Kharif harvest

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), DesOwen Lotion, 0.05 per cent of Galderma Laboratories LP. Desonide Lotion is low to medium potency corticosteroids indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Granules India informed the bourses on Saturday that United States Food & Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc (GPI) for Ramelteon tablets, 8 mg

Global rating agency in its latest report stated that in order to restore loss-absorbing buffers due to the COVID-19 hit, India’s state-run banks may need Rs 1.90 to 2.10 lakh crore of external capital over the next two years

PNB Housing Finance informed the bourses that its board of directors at its meeting held on August 19, 2020, have approved the fundraising plan through equity capital aggregating up to Rs 1,800 crore through preferential issue or rights issue